切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2021, Vol. 15 ›› Issue (01) : 70 -74. doi: 10.3877/cma.j.issn.1674-0793.2021.01.018

所属专题: 文献

综述

经皮机械性血栓清除术治疗下肢深静脉血栓形成的研究进展
李观强1, 孙元2, 张喜成2,()   
  1. 1. 116044 大连医科大学研究生院;225001 扬州,江苏省苏北人民医院血管外科
    2. 225001 扬州,江苏省苏北人民医院血管外科
  • 收稿日期:2020-08-29 出版日期:2021-02-01
  • 通信作者: 张喜成

Advances of percutaneous mechanical thrombectomy in the treatment of lower extremity deep vein thrombosis

Guanqiang Li1, Yuan Sun2, Xicheng Zhang2,()   

  1. 1. Graduate School of Dalian Medical University, Dalian 116044, China; Department of Vascular Surgery, Northern Jiangsu People’s Hospital, Yangzhou 225001, China
    2. Department of Vascular Surgery, Northern Jiangsu People’s Hospital, Yangzhou 225001, China
  • Received:2020-08-29 Published:2021-02-01
  • Corresponding author: Xicheng Zhang
引用本文:

李观强, 孙元, 张喜成. 经皮机械性血栓清除术治疗下肢深静脉血栓形成的研究进展[J/OL]. 中华普通外科学文献(电子版), 2021, 15(01): 70-74.

Guanqiang Li, Yuan Sun, Xicheng Zhang. Advances of percutaneous mechanical thrombectomy in the treatment of lower extremity deep vein thrombosis[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2021, 15(01): 70-74.

静脉血栓栓塞症发病率逐渐增加,即使是在标准抗凝治疗下,仍然有70%以上的患者会发生血栓形成后综合征(PTS),这将严重降低患者生活质量,增加经济负担。因此,快速去除血栓,恢复静脉通路,减少PTS的发生成为近年来临床关注的重点。目前的治疗方法有系统溶栓、导管接触性溶栓(CDT)、手术取栓、血栓抽吸、经皮机械取栓(PMT)等,其中PMT可通过不同物理方法快速清除血栓,减少溶栓药物的使用,虽然目前尚无高质量证据证明其相对于其他方式有更好的安全性及有效性,但PMT为临床医师提供了更多的选择,从而实现个体化医疗,获得最佳的临床效果。本文旨在对目前常见的PMT在原理、特点及局限性等方面进行综述。

The incidence of venous thromboembolism is gradually increasing. More than 70% of patients receiving standard anticoagulation treatment suffered from post-thrombotic syndrome (PTS), which will seriously reduce the quality of life and increase the economic burden. Therefore, rapid removal of thrombus, restoration of venous flow and reduce the incidence of PTS have become the focus of clinical research in recent years. The current treatment methods include systemic thrombolysis, catheter-directed thrombolysis (CDT), surgical thrombectomy, thrombus aspiration, percutaneous mechanical thrombectomy (PMT), et al. PMT can rapidly remove acute or subacute thrombus through different physical methods and reduce the use of thrombolytic drugs. Although there is no high-quality evidence to prove that PMT has better safety and effectiveness than other treatments, it provides more choices for clinicians to achieve the best clinical effects. This paper aims to summarize the basic principles, advantages and limitations of PMT.

表1 不同方式的经皮机械取栓(PMT)特点及局限性
[1]
Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism[J]. J Thromb Thrombolysis, 2016, 41(1): 3-14.
[2]
Galanaud JP, Monreal M, Kahn SR. Epidemiology of the post-thrombotic syndrome[J]. Thromb Res, 2018, 164: 100-109.
[3]
Calik ES, Dag O, Kaygin MA, et al. Pharmacomechanical thrombectomy for acute symptomatic lower extremity deep venous thrombosis[J]. Heart Surg Forum, 2015, 18(4): E178-E183.
[4]
Jenkins JS. Endovascular therapies to treat iliofemoral deep venous thrombosis[J]. Prog Cardiovasc Dis, 2011, 54(1): 70-76.
[5]
Blackwood S, Dietzek AM. Pharmacomechanical thrombectomy: 2015 update[J]. Expert Rev Cardiovasc Ther, 2016, 14(4): 463-475.
[6]
Shi HJ, Huang YH, Shen T, et al. Percutaneous mechanical thrombectomy combined with catheter-directed thrombolysis in the treatment of symptomatic lower extremity deep venous thrombosis[J]. Eur J Radiol, 2009, 71(2): 350-355.
[7]
Shi HJ, Huang YH, Shen T, et al. Percutaneous mechanical thrombectomy for acute massive lower extremity deep venous thrombosis[J]. Surg Laparosc Endosc Percutan Tech, 2011, 21(1): 50-53.
[8]
Gagne P, Khoury T, Zadeh BJ, et al. A multicenter, retrospective study of the effectiveness of the Trellis-8 system in the treatment of proximal lower-extremity deep vein thrombosis[J]. Ann Vasc Surg, 2015, 29(8): 1633-1641.
[9]
Mahmoud O, Vikatmaa P, Räsänen J, et al. Catheter-directed thrombolysis versus pharmacomechanical thrombectomy for upper extremity deep venous thrombosis: A cost-effectiveness analysis[J]. Ann Vasc Surg, 2018, 51: 246-253.
[10]
Yuksel A, Tuydes O. Midterm outcomes of pharmacomechanical thrombectomy in the treatment of lower extremity deep vein thrombosis with a rotational thrombectomy device[J]. Vasc Endovascular Surg, 2017, 51(5): 301-306.
[11]
Lichtenberg M, Breuckmann F, Kramer V, et al. Effectiveness of the Pulsar-18 self-expanding stent with optional drug-coated balloon angioplasty in the treatment of femoropopliteal lesions - the BIOFLEX PEACE All-Comers Registry[J]. Vasa, 2019, 48(5): 425-432.
[12]
Song XJ, Liu ZL, Zeng R, et al. The efficacy and safety of AngioJet rheolytic thrombectomy in the treatment of subacute deep venous thrombosis in lower extremity[J]. Ann Vasc Surg, 2019, 58: 295-301.
[13]
Liu G, Zhao Z, Cui C, et al. Endovascular management of extensive lower extremity acute deep vein thrombosis with AngioJet rheolytic thrombectomy plus catheter-directed thrombolysis from contralateral femoral access[J]. Phlebology, 2019, 34(4): 257-265.
[14]
Dumantepe M, Uyar I. The effect of Angiojet rheolytic throm-bectomy in the endovascular treatment of lower extremity deep venous thrombosis[J]. Phlebology, 2018, 33(6): 388-396.
[15]
Biederer J, Charalambous N, Paulsen F, et al. Treatment of acute pulmonary embolism: local effects of three hydrodynamic thrombectomy devices in an ex vivo porcine model[J]. J Endovasc Ther, 2006, 13(4): 549-560.
[16]
Angle JF, Spinosa DJ, Hagspiel KD, et al. Management of acute lower extremity embolus with use of the oasis thrombectomy device and suction embolectomy[J]. J Vasc Interv Radiol, 2000, 11(10): 1331-1335.
[17]
Tsuji A, Yamada N, Ota S, et al. Early results of rheolytic thrombectomy in patients with proximal deep vein thrombosis[J]. Circ J, 2011, 75(7): 1742-1746.
[18]
丁锦辉,丁贺义,蒋米尔. 下肢深静脉血栓腔内治疗进展[J]. 临床外科杂志, 2016, 24(8): 638-640.
[19]
Francis CW, Onundarson PT, Carstensen EL, et al. Enhancement of fibrinolysis in vitro by ultrasound[J]. J Clin Invest, 1992, 90(5): 2063-2068.
[20]
李晓强,周为民,余朝文, 等. 超声消融球囊扩张联合动静脉瘘治疗下肢深静脉血栓[J]. 解剖与临床, 2005, 10(1): 38-39, 44.
[21]
Notten P, Ten Cate-Hoek AJ. Catheter interventions: an unresolved clinical controversy - Authors’ reply[J]. Lancet Haematol, 2020, 7(3): e190.
[22]
Lu T, Loh TM, El-Sayed HF, et al. Single-center retrospective review of ultrasound-accelerated versus traditional catheter-directed thrombolysis for acute lower extremity deep venous thrombosis[J]. Vascular, 2017, 25(5): 525-532.
[23]
Wildberger JE, Schmitz-Rode T, Haage P, et al. Ultrasound thrombolysis in hemodialysis access: in vitro investigation[J]. Cardiovasc Intervent Radiol, 2001, 24(1): 53-56.
[24]
Fischell TA, Haddad N, Baskerville S, et al. Ultrasound throm-bolysis for the treatment of thrombotic occlusion of degenerated saphenous vein grafts[J]. Catheter Cardiovasc Interv, 2000, 50(1): 90-95.
[25]
Vedantham S, Goldhaber SZ, Julian JA, et al. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis[J]. N Engl J Med, 2017, 377(23): 2240-2252.
[26]
Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)[J]. Chest, 2008, 133(6 Suppl): 454S-545S.
[27]
Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST Guideline and expert panel report[J]. Chest, 2016, 149(2): 315-352.
[28]
Yin SW, Guo LW, Bian L, et al. Evaluation of percutaneous mechanical thrombectomy via the AngioJet system combined with catheter-directed thrombolysis for the treatment of symptomatic lower extremity deep venous thrombosis[J]. Ann Vasc Surg, 2020, 65: 66-71.
[29]
Zhu Y, Li L, Liu Z, et al. Single-stage treatment of AngioJet rheolytic thrombectomy and stenting for iliac vein compression syndrome with secondary acute iliofemoral deep vein thrombosis[J]. Ann Vasc Surg, 2019, 61: 384-393.
[30]
Thomas M, Hollingsworth A, Mofidi R. Endovascular management of acute lower limb deep vein thrombosis: A systematic review and Meta-analysis[J]. Ann Vasc Surg, 2019, 58: 363-370.
[1] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[2] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[3] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[4] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[5] 刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[6] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[7] 石海波, 赵旭东, 王聪, 曲巍. 气肿性肾盂肾炎、气肿性膀胱炎并脓毒性休克一例报道并文献复习[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 644-647.
[8] 林逸, 钟文龙, 李锴文, 何旺, 林天歆. 广东省医学会泌尿外科疑难病例多学科会诊(第15期)——转移性膀胱癌的综合治疗[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 648-652.
[9] 袁园园, 岳乐淇, 张华兴, 武艳, 李全海. 间充质干细胞在呼吸系统疾病模型中肺组织分布及治疗机制的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 374-381.
[10] 国文凯, 纪鹏程, 毕靖茹, 谢院生. IgA 肾病的十种治疗措施[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 327-333.
[11] 帖璇, 苏晓乐, 王利华. 抗中性粒细胞胞质抗体相关性血管炎治疗研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 345-351.
[12] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[13] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[14] 张平骥, 徐钰, 李天水, 庞文翼, 符师宁, 张梦圆. 重症患者镇静治疗现状及期望的调查研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 562-567.
[15] 王昌前, 林婷婷, 宁雨露, 王颖杰, 谭文勇. 光免疫治疗在肿瘤领域的临床应用新进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 575-583.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?